DDHD2 possesses both lipase and transacylase capacities that remodel triglyceride acyl chains
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2500527122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Lingshuang Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Cell Biology, Stony Brook University, Stony Brook NY 11794. Hauptthemen laut MEDLINE: Triglycerides, Lipase, Acyltransferases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Alfred P. Sloan Foundation (APSF), HHS | NIH | National Institute of General Medical Sciences (NIGMS), American Heart Association (AHA).
Abstract (Originalsprache)
Hereditary spastic paraplegia subtype SPG54 is a genetic neurological disorder caused by mutations in the DDHD2 gene. Excessive lipid droplet accumulation is observed in the brains of SPG54 patients and DDHD2 knockout mice, consistent with DDHD2’s reported neutral lipase activity. Here, we find recombinant human DDHD2 preferentially hydrolyzes diacylglycerol (DAG) over phospholipids, with a slight preference for DAG over triacylglycerol (TAG). DDHD2 also exhibits transacylase activity, which enables transfer of acyl chains from TAGs to DAGs and monoacylglycerols to remodel the acyl chains of TAGs. A predicted hydrophobic amphipathic helix on DDHD2 is essential for lipid droplet binding in vitro and in cells, and its lack reduces the enzymatic activity and TAG acyl chain remodeling. Adipose triglyceride lipase, but not hormone sensitive lipase, also has transacylation activity and can remodel TAG acyl chains, but to a lesser extent than DDHD2. Taken together, this provides evidence that DDHD2 is a neutral lipid lipase and transacylase whose broad specificity enables TAG acyl-chain remodeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Cell Biology, Stony Brook University, Stony Brook NY 11794.
- Laboratoire de Physique de l'École Normale Supérieure, École Normale Supérieure, Université Paris Sciences et Lettres, CNRS, Sorbonne Université, Université Paris Cité, Paris F-75005, France.
- Department of Medicine, Renaissance School of Medicine at Stony Brook University, Stony Brook NY 11794.
ORCID-Profile: Lingshuang Wu, Mohyeddine Omrane, Jiyao Chai, Shujuan Gao, Abdou Rachid Thiam, Daniel Canals, Michael V Airola
Förderung
- Alfred P. Sloan Foundation (APSF)
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
- American Heart Association (AHA)
- SUNY | Stony Brook University (SBU)
- Agence Nationale de la Recherche (ANR)
- NCI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Wu, L., Choi, Y. M., Omrane, M., Chai, J., Gao, S., Thiam, A. R., Canals, D., & Airola, M. V. (2025). DDHD2 possesses both lipase and transacylase capacities that remodel triglyceride acyl chains. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2500527122
Vancouver
Wu L, Choi YM, Omrane M, Chai J, Gao S, Thiam AR, et al. DDHD2 possesses both lipase and transacylase capacities that remodel triglyceride acyl chains. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2500527122
BibTeX
@article{Wu2025,
author = {Wu, Lingshuang and Choi, Yong Mi and Omrane, Mohyeddine and Chai, Jiyao and Gao, Shujuan and Thiam, Abdou Rachid and Canals, Daniel and Airola, Michael V},
title = {DDHD2 possesses both lipase and transacylase capacities that remodel triglyceride acyl chains},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2500527122}
}
EUVIMED